AprilBio Co.,Ltd.
Develops long-acting biologic drugs for autoimmune diseases and oncology using its SAFA™ platform.
397030 | KO
Overview
Corporate Details
- ISIN(s):
- N/A
- LEI:
- Country:
- South Korea
- Address:
- 강원도 춘천시 강원대학길 1 의생명과학대학 B동 602호, 춘천시
- Website:
- http://www.aprilbio.com/en/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
AprilBio Co., Ltd. is a clinical-stage biotechnology company that develops innovative biologic drugs. The company's operations are centered on its proprietary SAFA™ (anti-Serum Albumin Fab Associated) platform technology, a long-acting protein engineering solution. The SAFA platform utilizes an albumin binder to extend the half-life of antibody fragments, enhancing their efficacy and safety. AprilBio's research and development pipeline is focused on creating novel therapeutics, branded as SAFAbody™, primarily for the treatment of autoimmune diseases and oncology. The company aims to address unmet medical needs by advancing drug candidates through early clinical development stages for subsequent technology transfer or licensing.
This is a Fraction of the Available Data.
You're viewing a limited, static snapshot. Professionals use our API to get real-time, AI-ready data for AprilBio Co.,Ltd. and 9,000+ other companies.
Stop analyzing yesterday's news. Start building a real-time advantage.
Request Enterprise API AccessFilings
| Date | Filing | Language | Size | Actions |
|---|---|---|---|---|
| 2025-09-18 00:00 |
Share Issue/Capital Change
전환청구권행사 (제1회차)
|
Korean | 11.8 KB | |
| 2025-09-16 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | |
| 2025-09-16 00:00 |
Major Shareholding Notification
주식등의대량보유상황보고서(일반)
|
Korean | 180.5 KB | |
| 2025-09-12 00:00 |
Report Publication Announcement
기업설명회(IR)개최
|
Korean | 6.8 KB | |
| 2025-09-05 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.1 KB | |
| 2025-09-03 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | |
| 2025-08-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.2 KB | |
| 2025-08-18 00:00 |
Major Shareholding Notification
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 25.0 KB | |
| 2025-08-13 00:00 |
Share Issue/Capital Change
주식매수선택권부여에관한신고
|
Korean | 16.7 KB | |
| 2025-08-13 00:00 |
Interim Report
반기보고서 (2025.06)
|
Korean | 1.1 MB | |
| 2025-08-06 00:00 |
Regulatory News Service
임원ㆍ주요주주특정증권등소유상황보고서
|
Korean | 24.9 KB |
Automate Your Workflow. Get a real-time feed of all AprilBio Co.,Ltd. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
No Financial Data Available
Standardized financial statements for the selected period are not yet available.
Need More History? Access decades of standardized financials for AprilBio Co.,Ltd. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
